• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ALINITY C CARBON DIOXIDE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ALINITY C CARBON DIOXIDE Back to Search Results
Catalog Number 07P72-30
Medical Device Problem Codes Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Health Effect - Clinical Code No Patient Involvement (2645)
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Correction/removal reporting number = 3002809144-10/24/19-009-r.The investigation into this matter found that the amount of co2 absorbed was higher with increased reagent carousel rotation and when the volume of the reagent in the cartridge is reduced.This phenomenon could be detected as a shift in qc and also incorrect patient results.A product recall letter was sent to all customers who have received shipments of the impacted lots of the alinity c carbon dioxide reagent kit.The letter instructs the following: immediately discontinue use of the alinity c carbon dioxide 15000t kit and destroy any remaining inventory as existing modes of control are not effective for the large cartridge.Run two levels of co2 controls every hour with the use of the current alinity c carbon dioxide 3000t kit, instead of every 24 hours, and perform assay calibration as needed to minimize the potential to generate incorrect results.All current inventory of alinity c carbon dioxide (ln 07p7220), will be reworked to include a kit stuffer instructing customers to run qc every hour.In future lots of the alinity c carbon dioxide 3000t kit, the reagent cartridge fill volume will be increased from 12.7 ml to 20.7 ml, which has been confirmed to minimize co2 absorption.
 
Event or Problem Description
The customer reported the carbon dioxide (co2) controls have been going up during the day.The customer had been instructed to run the controls every 2 hours but was still experiencing the issue.The customer loaded a new co2 reagent on the alinity analyzer and the internal quality controls were ok.There was no reported impact to patient management.
 
Additional Manufacturer Narrative
Correction/removal reporting number = 3002809144-10/24/19-009-r on 04dec2019, a mistake was identified for date received by manufacturer.This follow-up mdr is being submitted to correct the date from 11nov2019 to 05nov2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALINITY C CARBON DIOXIDE
Common Device Name
CARBON DIOXIDE
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
MDR Report Key9350050
Report Number3002809144-2019-00929
Device Sequence Number2852804
Product Code KHS
UDI-Device Identifier00380740121600
UDI-Public00380740121600
Combination Product (Y/N)N
Initial Reporter CountryFR
PMA/510(K) Number
K060295
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source foreign,health professional
Initial Reporter Occupation Other Health Care Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 12/04/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number07P72-30
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer 11/11/2019
Supplement Date Received by Manufacturer12/04/2019
Initial Report FDA Received Date11/20/2019
Supplement Report FDA Received Date12/04/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
3002809144-10/24/19-009-
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ALINITY C PROCESSING MODULE; ALINITY C PROCESSING MODULE; LN 03R67-01, SN (B)(4) ; LN 03R67-01, SN (B)(4)
-
-